Literature DB >> 6991338

Nonenzymatic glucosylation of serum proteins and hemoglobin: response to changes in blood glucose levels in diabetic rats.

J F Day, C G Ingebretsen, W R Ingebretsen, J W Baynes, S R Thorpe.   

Abstract

The relationship between concentrations of blood glucose and nonenzymatically glucosylated serum proteins was studied in rats with alloxan-induced diabetes of varying severity. Fasting serum glucose correlated strongly with both glucosylated albumin (r = 0.91, P less than 0.001) and glucosylated serum protein (r = 0.93, P less than 0.001). The relative rates of response of serum protein and hemoglobin glycosylation to changes in blood glucose were also compared. Following withdrawal of insulin from diabetic rats, the half-times to reach new steady state levels of blood glucose, glucosylated serum proteins, and glycohemoglobins were about 2, 3, and 8 days, respectively. Similarly, on reinstitution of insulin therapy, the half-times for these same indices to return to baseline values were 2, 3.5, and 15 days, respectively. Changes in glucosylated albumin were more sensitive than glycohemoglobins to changes in serum glucose, consistent with the observation that albumin was glucosylated at about 10 times the rate for hemoglobin in incubations in vitro. These data indicate that glucosylated serum protein measurements can serve as a sensitive, short-term integrator of blood glucose homeostasis in diabetes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991338     DOI: 10.2337/diab.29.7.524

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  19 in total

Review 1.  Recent topics in chemical and clinical research on glycated albumin.

Authors:  Yuki Ueda; Hideyuki Matsumoto
Journal:  J Diabetes Sci Technol       Date:  2015-01-21

2.  Prevention of decline in renal function in the diabetic db/db mouse.

Authors:  M P Cohen; R S Clements; J A Cohen; C W Shearman
Journal:  Diabetologia       Date:  1996-03       Impact factor: 10.122

Review 3.  β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.

Authors:  Yoshifumi Saisho
Journal:  World J Diabetes       Date:  2015-02-15

4.  Glycated albumin modified by Amadori adducts modulates aortic endothelial cell biology.

Authors:  M P Cohen; E Hud; V Y Wu; F N Ziyadeh
Journal:  Mol Cell Biochem       Date:  1995-02-09       Impact factor: 3.396

5.  Effects of glycated albumin on mesangial cells: evidence for a role in diabetic nephropathy.

Authors:  F N Ziyadeh; M P Cohen
Journal:  Mol Cell Biochem       Date:  1993-08-11       Impact factor: 3.396

6.  Interaction of human endothelial cells with elevated glucose concentrations and native and glycosylated low density lipoproteins.

Authors:  M Lorenzi; E Cagliero; B Markey; T Henriksen; J L Witztum; T Sampietro
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

7.  Correlation between macrovascular disease as assessed by bioimpedance plethysmography and various parameters used to assess diabetic "control".

Authors:  A N Elias; E S Domurat; R Friis; L J Valenta
Journal:  J Natl Med Assoc       Date:  1989-04       Impact factor: 1.798

8.  Different behaviour of haemoglobin A1a-c and glycosyl-albumin levels during recovery from diabetic ketoacidosis and non-acidotic coma.

Authors:  R Dolhofer; R Renner; O H Wieland
Journal:  Diabetologia       Date:  1981-09       Impact factor: 10.122

9.  Improved Monitoring of the Hyperglycemic State in Type 1 Diabetes Patients by Use of the Glycoalbumin/HbA1c Ratio.

Authors:  Takatoshi Imai; Yoichi Oikawa; Akira Shimada
Journal:  Rev Diabet Stud       Date:  2007-05-10

10.  Selective depletion of small basic non-glycosylated proteins in diabetes.

Authors:  F C Samaniego; F Berry; J F Dice
Journal:  Biochem J       Date:  1981-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.